ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women
(ندگان)پدیدآور
Isakova, JainagulVinnikov, DenisBukuev, NurbekTalaibekova, ElnuraAdasheva, Naziraنوع مدرک
TextResearch Articles
زبان مدرک
Englishچکیده
Background: The aim of this study was to ascertain the magnitude of association of gene ТР53 Arg72Pro polymorphicmarker with cervical cancer (CC) in Kyrgyz women. Methods: We identified and included 205 women of Kyrgyzethnicity for this case-control study, of whom N=103 were women (mean age 53.5 ± 10.0 years) with histologicallyconfirmed CC and N=102 controls (mean age 46.5 ± 8.5 years). We detected human papilloma virus (HPV) DNA types16 and 18 using polymerase chain reaction (PCR) with hybridization/fluorescent detection. Genotypes of ТР53 geneArg72Pro polymorphism were identified using PCR-RFLP assay. Results: Eighty-eight percent (90/103) women withCC had HPV, of whom 43.4% (39/90) had HPV type 16, 24.4% (22/90) had HPV type 18, whereas 32.2% (29/90)carried both types. The univariate analysis of allele and genotype distribution of Arg72Pro polymorphic marker of ТР53gene showed no difference between CC and control groups (χ2=1.24, р=0.54). However, when CC cases associated withHPV were tested against controls, Arg72 allele and Arg72Arg genotype prevalence were greater compared to controls(χ²=7.25; р=0.027 for genotypes and χ²=6.83; р=0.009 for alleles). In HPV-positive women, Arg72Arg genotype ofТР53 gene was associated with a 1.85-fold increase in the likelihood of CC (OR=1.85 [95% confidence interval (CI)1.03-3.32]), whereas Arg72 allele increased this likelihood 1.94-fold (OR=1.94 [95% CI 1.20-3.15]). Conclusions:Arg72Arg genotype and Arg72 allele of ТР53 gene in Kyrgyz women increase the risk of HPV-associated CC.
کلید واژگان
ТР53 geneArg72Pro
Polymorphism
Cervical cancer
Kyrgyz population
Gynaecological oncology
شماره نشریه
4تاریخ نشر
2019-04-011398-01-12
ناشر
West Asia Organization for Cancer Prevention (WAOCP)سازمان پدید آورنده
Institute of Molecular Biology and Medicine, Bishkek, Kazakhstan.Institute of Molecular Biology and Medicine, Bishkek, Kazakhstan.
National Center of Oncology and Hematology, Bishkek, Kazakhstan.
Institute of Molecular Biology and Medicine, Bishkek, Kazakhstan.
Institute of Molecular Biology and Medicine, Bishkek, Kazakhstan.
شاپا
1513-73682476-762X




